Evidence map›Paper›PMID 18803283›Full record

ArticleJournal of neuroscience research2009

9-Cis-retinoic acid reduces ischemic brain injury in rodents via bone morphogenetic protein.

Hui Shen, Yu Luo, Chi-Chung Kuo, Xiaolin Deng, Chen-Fu Chang, Brandon K Harvey, Barry J Hoffer, Yun Wang

Open access · greenAbstract read
In one paragraph

Article in Journal of neuroscience research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hui ShenNational Institute on Drug Abuse, Intramural Research Program, Baltimore, Maryland 21224, USA.
Yu Luo
Chi-Chung Kuo
Xiaolin Deng
Chen-Fu Chang
Brandon K Harvey
Barry J Hoffer
Yun Wang
National Institute on Drug Abuse · US

Funding

Gene Delivery and AddictionZIADA000526 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2022
$3.2M
Gene Therapy And NeurodegenerationZIADA000443 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HARVEY, BRANDON · 2009 to 2020
$2.7M
Neuroprotective and neuroregenerative effects of trophic factorsZIADA000429 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI WANG, YUN · 2009 to 2013
$2.4M
Neuroprotective/regenerative effects of small molecules and trophic factorsZIADA000461 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI WANG, YUN · 2009 to 2013
$2.3M
THERAPEUTIC STRATEGIES FOR STROKEZ01DA000429 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI WANG, YUN · 1999 to 2008
$1.3M
Intramural NIH HHS Z01 DA000429
6 · The paper itself

Abstract

Retinoic acid (RA), a biologically active derivative of vitamin A, has protective effects against damage caused by H(2)O(2) or oxygen-glucose deprivation in mesangial and PC12 cells. In cultured human osteosarcoma cells, RA enhances the expression of bone morphogenetic protein-7 (BMP7), a trophic factor that reduces ischemia- or neurotoxin-mediated neurodegeneration in vivo. The purpose of this study is to examine whether RA reduces ischemic brain injury through a BMP7 mechanism. We found that intracerebroventricular administration of 9-cis-retinoic acid (9cRA) enhanced BMP7 mRNA expression, detected by RT-PCR, in rat cerebral cortex at 24 hr after injection. Rats were also subjected to transient focal ischemia induced by ligation of the middle cerebral artery (MCA) at 1 day after 9cRA injection. Pretreatment with 9cRA increased locomotor activity and attenuated neurological deficits 2 days after MCA ligation. 9cRA also reduced cerebral infarction and TUNEL labeling. These protective responses were antagonized by the BMP antagonist noggin given 1 day after 9cRA injection. Taken together, our data suggest that 9cRA has protective effects against ischemia-induced injury, and these effects involve BMPs.

Indexed as

AlitretinoinAnimalsBone Morphogenetic Protein 7Brain IschemiaCarrier ProteinsGene ExpressionInfarction, Middle Cerebral ArteryInjections, IntraventricularIn Situ Nick-End LabelingMaleMotor ActivityNeuroprotective AgentsNoggin ProteinRatsRats, Sprague-DawleyRecovery of FunctionAlitretinoinBone Morphogenetic Protein 7Carrier ProteinsNeuroprotective AgentsNoggin ProteinRNA, MessengerTretinoin

Identifiers

PMID18803283
PMCPMC2628966
OpenAlexW2144936065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.